These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11918520)
1. Pathophysiology and first-line treatment of osteoarthritis. Hogue JH; Mersfelder TL Ann Pharmacother; 2002 Apr; 36(4):679-86. PubMed ID: 11918520 [TBL] [Abstract][Full Text] [Related]
2. Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitors. Schnitzer TJ Clin Ther; 2001 Mar; 23(3):313-326; discussion 311-2. PubMed ID: 11318071 [TBL] [Abstract][Full Text] [Related]
3. The cyclooxygenase-2 inhibitors: safety and effectiveness. Kaplan-Machlis B; Klostermeyer BS Ann Pharmacother; 1999 Sep; 33(9):979-88. PubMed ID: 10492503 [TBL] [Abstract][Full Text] [Related]
4. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. Hochberg MC Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with cyclooxygenase-2 inhibitors. Lanas A Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. Tindall E J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176 [TBL] [Abstract][Full Text] [Related]
7. Use of NSAIDs for the chemoprevention of colorectal cancer. Herendeen JM; Lindley C Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811 [TBL] [Abstract][Full Text] [Related]
8. Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs? Simon LS Curr Opin Rheumatol; 2000 May; 12(3):163-70. PubMed ID: 10803743 [TBL] [Abstract][Full Text] [Related]
9. Osteoarthritis therapy--are there still unmet needs? Laufer S Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i9-15. PubMed ID: 14752170 [TBL] [Abstract][Full Text] [Related]
10. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea. Lee MC; Lee S; Suh DC; Kim J; Kong SX; Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981 [TBL] [Abstract][Full Text] [Related]
11. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
12. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Buttar NS; Wang KK Mayo Clin Proc; 2000 Oct; 75(10):1027-38. PubMed ID: 11040851 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2: a therapeutic target. Turini ME; DuBois RN Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462 [TBL] [Abstract][Full Text] [Related]
14. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications. Pascucci RA J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181 [TBL] [Abstract][Full Text] [Related]
15. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg MC Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246 [TBL] [Abstract][Full Text] [Related]
16. Pain management in osteoarthritis: the role of COX-2 inhibitors. Lane NE J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647 [TBL] [Abstract][Full Text] [Related]
17. Trial of tramadol/acetaminophen tablets for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug. Ellman MH; Curran J J Rheumatol; 2005 Mar; 32(3):568; author reply 568-9. PubMed ID: 15742426 [No Abstract] [Full Text] [Related]
18. Update of ACR guidelines for osteoarthritis: role of the coxibs. Schnitzer TJ; J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S24-30; discussion S31-4. PubMed ID: 11992747 [TBL] [Abstract][Full Text] [Related]